
|Articles|February 1, 2004
Adjustable IOL offers versatile platform for the future
Salt Lake City-The Light Adjustable Lens (LAL, Calhoun Vision) is an exciting new technology for the future, said Nick A. Mamalis, MD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Iolyx Therapeutics and Laboratoires Théa enter into agreement over ILYX-002 for the treatment of OSD
2
Avisi Technologies treats first patient in SAPPHIRE trial for glaucoma
3
PainReform launches development plan for OcuRing-K, readies phase 2 trial
4
First patient treated in ViaLase’s IDE trial
5















































.png)


